Document:

Severance Agreement, dated September 9, 1999

 Exhibit 10.14 
  
 SEVERANCE BENEFITS AGREEMENT 
  

This SEVERANCE BENEFITS AGREEMENT (the “Agreement”), made this 8th day of September, 1999 is entered into by and between Gensym Corporation,
with its principal place of business in Cambridge, Massachusetts (the “Company”), and Carl Schultz (the “Executive”) (together, the “parties”). 
  
 WHEREAS, the Company wishes to provide the Executive with severance benefits in the event of the Executive’s separation
from the Company under the circumstances provided for herein; 
  
 NOW, THEREFORE, in consideration of the Executive’s continued employment by the Company and other good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties agree as follows: 
  
 1. Eligibility for Severance
Benefits.    In the event the Executive is discharged from employment by the Company without cause, as that term is defined in Paragraph 3 below, the Executive shall be entitled to the following severance benefits:

  
 a) Severance
Pay.    The Company shall pay the Executive severance pay in an aggregate amount which is equivalent to six (6) months of the Executive’s annual base salary in effect on the last day of the Executive’s employment
with the Company (“Separation Date”), less all applicable state and federal taxes. The severance pay will be paid to the Executive in installments in accordance with the Company’s regular payroll practices. 
  
 b) COBRA Benefits.    Effective as
of the Separation Date, the Executive shall be considered to have elected to continue receiving group medical insurance pursuant to the federal “COBRA” law, 29 U.S.C. §1161 et seq. For a period of six (6) months after
the Separation Date (the “COBRA Benefits Period”), the Company shall continue to pay the share of the premium for such coverage that is paid by the Company for active employees similarly-situated to the Effective shall pay the remaining
balance of any premium costs, and all premium costs after the COBRA Benefits Period, on a monthly basis for as long as, and to the extent that, the Executive remains eligible for COBRA continuation. 
  
 2. Severance Benefits Unavailable.    The
Executive shall not be entitled to any severance benefits if the Executive’s employment with the Company is ended under any of the following circumstances: 
  
 a) Termination for Cause.    The Executive’s employment is terminated by the
Company for cause, as that term is defined in Paragraph 3 below; 
  
 b) Termination for Death or Disability.    The Executive’s employment is terminated as a result of the Executive’s death, or because of the Executive’s physical or mental
disability which renders the Executive unable to perform the essential functions of the Executive’s job for a period of more than 90 days, whether or not consecutive, during any 360-day period. A determination of disability shall be made by a
physician satisfactory to both the Executive and the Company, provided that if the Executive and the Company do not agree on a physician, the Executive and the Company shall each select a physician and these two together shall select a
third physician, whose determination as to disability shall be binding on all parties; 
  
 c) Resignation.    The Executive provides the Company with oral or written notice of resignation from
employment with the Company. 
  
 3.
Cause.    For purposes of this Agreement, “cause” for termination shall be deemed to exist upon (a) a good faith finding by the Company of the failure of the Executive to perform his assigned duties for the
Company, dishonesty, gross negligence or misconduct, or (b) the conviction of the Executive of, or the entry of a pleading of guilty or nolo contendere by the Executive to, any crime involving moral turpitude or any felony. 
  
 4. Employment at Will.    Nothing in this
Agreement may be construed or interpreted as an agreement, either expressed or implied, to employ the Executive for any stated term, and shall in no way alter the at-will nature of the Executive’s employment with the Company, allowing both the
Executive and the Company to terminate the employment relationship with or without cause at any time without notice. 

 5. Entire Agreement.    This Agreement contains and constitutes the entire
understanding and agreement between the parties hereto with respect to severance benefits and cancels all previous oral and written negotiations, agreements, commitments, understandings and writings in connection therewith. 
  
 6. Amendment.    This Agreement shall be binding
upon the parties and may not be abandoned, supplemented, changed or modified in any manner, orally or otherwise, except by an instrument in writing of concurrent or subsequent date signed by a duly authorized representative of the parties hereto.
This Agreement is binding upon and shall inure to the benefit of the parties and their respective agents, assigns, heirs, executors, successors and administrators. 
  
 7. Validity.    Should any provision of this Agreement be declared or be determined by any court
of competent jurisdiction to be illegal, invalid or unenforceable, the validity of the remaining parts, terms, or provisions shall not be affected thereby and said illegal, invalid or unenforceable part, term or provision shall be deemed not to be a
part of this Agreement. 
  
 8. Applicable
Law.    This Agreement shall be governed by and interpreted under the laws of the Commonwealth of Massachusetts, without regard to conflict of laws provisions, and is binding upon and shall inure to the benefit of the parties
and their respective agents, assigns, heirs, executors, successors and administrators. The Executive hereby irrevocably submits to, acknowledges and recognizes the jurisdiction of the state and federal courts of Massachusetts (which courts, together
with all applicable appellate courts, for purposes of this Agreement, are the only courts of competent jurisdiction) over any suit, action, or other proceeding arising out of, under or in connection with this Agreement. 
  
 9. Voluntary Assent.    The Executive affirms that
no other promises or agreements of any kind have been made to or with him by any person or entity whatsoever to cause him to sign this agreement, and that he fully understands the meaning and intent of this Agreement. The Executive states and
represents that he has had an opportunity to fully discuss and review the terms of this Agreement with an attorney. The Executive further states and represents that he has carefully read this Agreement, understands the contents herein, freely and
voluntarily assents to all of the terms and conditions hereof, and signs his name of his own free act. 
  
 10. Counterparts.    This Agreement may be executed in two (2) signature counterparts, each of which shall constitute an
original, but all of which taken together shall constitute but one and the same instrument. 
  
 IN WITNESS WHEREOF, all parties have set their hand and seal to this Agreement as of the date written above. 
  

			
	 /s/ Carl Schultz

	  	 Date: 9/9/99

	 Carl Schultz
	  	 
		
	 GENSYM CORPORATION
	  	 
		
	 By its duly authorized agent
	  	 
		
	 /s/ Lowell B. Hawkinson

	  	 Date: 9/9/99

	 Lowell B. Hawkinson
	  	 
		
	 Title: Chairman & CEODescription of Annual Salaries of Named Executive Officers

 Exhibit 10.20 
  
 GENSYM CORPORATION 
  
 Annual Salaries of Named Executive Officers 
  
 As of March 30, 2005, the following are the base salaries (on an annual basis) of the Company’s named executive officers: 
  

				
	 Name and Title

	  	2005 Annual
Base Salary

	 Kim Mayyasi
 President and Chief Executive Officer
	  	$	275,000
	 Lowell B. Hawkinson
 Chairman and Chief Technology Officer
	  	$	180,000
	 Stephen D. Allison
 Vice President, Finance and Chief Financial Officer
	  	$	180,000
	 Carl D. Schultz
 Vice President, Operations
	  	$	130,000
	 Philippe C. Printz
 Vice President, Engineering
	  	$	140,000

  
 Messrs. Mayyasi and
Hawkinson serve as directors of the Company, but receive no additional or special compensation for serving as directors.Description of Compensation Arrangements for Non-Employee Directors

 Exhibit 10.21 
  
 GENSYM CORPORATION 
  
 Description of Compensation Arrangements with Non-Employee Directors 
  
 Directors of the Company who are also Company employees receive no additional or special compensation for serving as
directors. 
  
 Following is a description of the compensation
arrangements for the Company’s non-employee directors. 
  
 The Company pays its non-employee directors $12,000 annually, plus $1,000 for physical attendance at each meeting of the board of directors or $500 for participation in a board meeting telephonically. Non-employee
directors also receive a $1,500 quarterly retainer for each committee on which the director serves. Non-employee directors are also eligible to receive stock options. 
  
 In July 2003, the Company’s board of directors approved the temporary reduction of the board’s
cash compensation by 10% in conjunction with the temporary reduction of the salaries of senior management. The salaries of the Company’s executive officers were restored in April 2004, retroactive to January 1, 2004. Also in April 2004, the
board of directors approved the restoration of the board’s cash compensation to pre-reduction levels, retroactive to January 1, 2004. 
  
 Since January 1, 2003, each of the Company’s non-employee directors must receive 10%, and may elect to receive up to 100%, of his
board compensation in shares of the Company’s common stock in lieu of cash. Each director must make his election in increments of 10% and may only change his election effective as of two specified times each year. 
  
 Prior to January 1, 2005, upon initial election as a
director, each non-employee director of the Company was entitled to receive a nonstatutory option to purchase 10,000 shares of the Company’s common stock and on the first day of each calendar quarter each non-employee director was entitled to
receive an option to purchase 5,000 shares. Commencing January 1, 2005, upon initial election as a director, each non-employee director of the Company will be entitled to receive a nonstatuory option to purchase 10,000 shares of the Company’s
common stock on and the first day of each calendar quarter each non-employee director is entitled to receive an option to purchase 2,500 shares. All options granted to directors are granted at an exercise price equal to the fair market value of the
Company’s common stock on the date of the grant, are immediately exercisable and are exercisable for up to 10 years from the date of grant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}]]